Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1083  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission


ORIGINAL ARTICLE
Year : 2015  |  Volume : 7  |  Issue : 3  |  Page : 226-229

Assessment of treatment interruption among pulmonary tuberculosis patients: A cross-sectional study


1 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda, Warangal, Telangana, India
2 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda, Warangal, Telangana; Department of, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India
3 Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda; Department of, Balaji Institute of Pharmacy, Laknepally, Narsampet, Warangal, Telangana, India

Correspondence Address:
Srinivas Martha
Department of Pharmacy Practice, St. Peter's Institute of Pharmaceutical Sciences, Kakatiya University, Hanamkonda; Department of, Balaji Institute of Pharmacy, Laknepally, Narsampet, Warangal, Telangana
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0975-7406.160034

Rights and Permissions

Background: Multi-drug resistant tuberculosis (TB) is a rising peril of the TB control in India caused mostly by incomplete treatment. Aim: The aim was to assess the treatment interruption among pulmonary TB (PTB) patients. Materials and Methods: A cross-sectional study was carried out for a period of 9 months among PTB patients. Patients admitted with active pulmonary Koch's and history of anti-TB treatment (ATT) for 1-month or more from any source and who returns to treatment after not taking ATT consecutively for 2 months or more were included in the study. The data were collected from the patients or their caretakers to obtain the source of treatment given previously before default, number of treatment interruptions, phase and reasons for treatment interruption treatment. Results: A total of 107 defaulters were identified during the study period. In the present study, 62.6% of the patients interrupted treatment only once, 55.34% of the patient's early continuation (3-4 months) treatment, and 47.66% of the patient's only one reason for the treatment interruptions during the course of the treatment. The most common reason for the treatment interruptions were felt well with TB treatment (29.53%) followed by side effects (16.06%), lack of money (8.29%), and other reasons. Conclusion: The study revealed that most of the defaulters were in the age group between 35 and 60 years, male gender, illiterates, daily wage labor, and married. The treatment interruptions were minimized by putting the efforts to improve direct supervision; pretreatment counseling and retrieve treatment interrupters were recommended.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1382    
    Printed17    
    Emailed0    
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal